Exicure (NASDAQ:XCUR) Posts Earnings Results

Exicure (NASDAQ:XCUR) announced its earnings results on Tuesday. The company reported ($3.39) earnings per share (EPS) for the quarter, Zacks reports.

Exicure Trading Down 4.5 %

XCUR stock opened at $12.40 on Wednesday. The firm has a market cap of $32.31 million, a P/E ratio of -5.99 and a beta of 3.84. Exicure has a 12-month low of $1.44 and a 12-month high of $36.00. The stock’s 50 day simple moving average is $10.34 and its 200 day simple moving average is $9.39.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.